Use the Back button in your browser to see the other results of your search or to select another record.
| Effects of aerobic exercise on cardiorespiratory fitness and cardiovascular risk factors in long-term breast cancer survivors: a randomized controlled trial |
| Johansen SH, Saeter M, Sarvari SI, Reinertsen KV, Edvardsen E, Wisloff T, Scott JM, Grydeland M, Raastad T, Hallen J, Kiserud CE, Lie HC, Solberg PA, Haugaa KH, Jensen JSS, Vatningen LH, Thorsen L, Nilsen TS |
| JACC CardioOncology 2025 Jun;7(4):414-426 |
| clinical trial |
| This trial has not yet been rated. |
|
BACKGROUND: Cancer treatment may impair physiological adaptations to exercise therapy, yet no study has directly compared exercise effects between cancer survivors and cancer-naive control subjects. OBJECTIVES: This study sought to examine the effects of aerobic exercise in anthracycline-treated long-term survivors of breast cancer (BCS) and to compare the effects to cancer-naive women. METHODS: The CAUSE (CArdiovascUlar Survivors Exercise) trial was a 2-arm randomized controlled trial in which long-term BCS were assigned to thrice-weekly nonlinear aerobic exercise for 5 months (BCS exercise) or usual care (BCS usual care). A third group of similarly aged cancer-naive women completed the same exercise intervention. The primary outcome was cardiorespiratory fitness (CRF) (measured as VO2peak). Secondary outcomes included cardiovascular risk factors (cardiometabolic biomarkers and body composition) and patient-reported outcomes (subjective vitality and life satisfaction). RESULTS: Between October 2020 and February 2023, 140 BCS (aged 59.0 +/- 6.4 years; 11 +/- 1 years after treatment) and 69 cancer-naive women (aged 57.8 +/- 4.9 years) were enrolled. From baseline to post-exercise intervention, VO2peak increased by 1.2 +/- 2.6 mL/kg-1/min-1 in the BCS exercise, by 0.01 +/- 2.5 mL/kg-1/min-1 in the BCS usual care group (mean difference 1.3; 95% confidence interval (CI) 0.5 to 2.1; p = 0.002), and by 2.6 +/- 2.5 mL/kg-1/min-1 in non-cancer subjects (BCS exercise versus non-cancer subjects: mean difference -1.4; 95% CI -2.2 to -0.5; p = 0.003). No changes in cardiovascular risk factors were observed. Compared with BCS usual care, the BCS exercise group reported improved subjective vitality (mean difference 2.56; 95% CI 1.22 to 3.90; p < 0.001) and satisfaction with life (mean difference 1.68; 95% CI 0.43 to 2.93; p = 0.009). CONCLUSIONS: Although aerobic exercise improves CRF in anthracycline-treated long-term BCS, the response was less than one-half that observed in cancer-naive subjects.
|